Table 1 Model parameters
From: Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
Probabilities | |||||
|---|---|---|---|---|---|
Variable | No RX | rFVIIa (40 mcg) | rFVIIa (80 mcg) | Utilities | Range |
Mild post-ICH deficit (mRS 0–1) | 0. 08 | 0. 17 | 0. 21 | 0. 81 | 0. 70–0. 95 |
Moderate post-ICH deficit (mRS 2–3) | 0. 23 | 0. 29 | 0. 29 | 0. 55 | 0. 2–0. 65 |
Severe post-ICH deficit (mRS 4–5) | 0. 40 | 0. 37 | 0. 30 | 0. 25 | (-0. 2)-0. 45 |
Death after ICH | 0. 29 | 0. 18 | 0. 18 | 0 | 0 |
Arterial thromboembolic event | 0. 02 | 0. 02 | 0. 55 | ||
Probability of dying after ATE | 0. 29 | 0. 29 | |||